由Campylobacter ureolyticus引起的心脏吸水器是性输出
1Internal Medicine, Southern Illinois University School of Medicine, Springfield, USA.
Cureus
|April 15, 2024
概括
一种罕见的Campylobacter ureolyticus感染在一个病人身上引起了性心周溢血和心脏坦波纳德. 这一发现突显了新出现的病原体.
科学领域:
- 传染性疾病 传染性疾病
- 心脏病学 心脏病学
- 微生物学 微生物学
背景情况:
- 坎比洛巴克特 (Campylobacter ureolyticus) 通常与胃肠道感染有关.
- 这种病原体已在各种感染中被确定,包括口腔感染,脑膜炎和软组织感染.
- 之前没有记录过由C. ureolyticus引起的心周溢出.
研究的目的:
- 报告一个独特的性心周溢液和心脏坦波纳德病例,由Campylobacter ureolyticus引起.
- 突出C. ureolyticus作为一种新兴的病原体,具有更广泛的临床表现谱.
- 强调需要进一步研究C. ureolyticus的致病性和临床意义.
主要方法:
- 一个男性患者出现严重症状的病例报告.
- 临床检查,包括识别性心周溢液和心脏坦波纳德.
- 微生物培养和致病生物体的鉴定,Campylobacter ureolyticus.
主要成果:
- 患者出现了不适,呼吸不全,恶心和吐,迅速进展到败血症和阻塞性休克.
- 调查显示,性心周溢液导致心脏坦波纳德.
- 培养物确定了Campylobacter ureolyticus作为致病剂.
结论:
- 坎比洛巴克特 (Campylobacter ureolyticus) 可以在胃肠道外引起严重的,危及生命的感染,例如性心周溢血.
- 这一病例扩大了已知的C. ureolyticus感染的临床谱.
- 需要进一步的研究,以了解C. ureolyticus在人类疾病中的新兴作用.
更多相关视频
07:03Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
1.5K
05:34Author Spotlight: Development of an Enhanced Protocol for Rapid and Accurate Isolation of Campylobacter from Food Products
Published on: February 23, 2024
1.8K
相关概念视频
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pleural Effusion I: Introduction
948
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
948
Pleural Effusion II: Symptoms and Management
166
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
166
Esophageal Perforation-II: Clinical Manifestations and Management
58
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
58
Pneumothorax-II
141
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
141
